Zobrazeno 1 - 10
of 181
pro vyhledávání: '"Immunomodulating Agent"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Universidad Peruana de Ciencias Aplicadas (UPC)Repositorio Academico - UPCEuropean Urology.
El texto completo de este trabajo no está disponible en el Repositorio Académico UPC por restricciones de la casa editorial donde ha sido publicado.
“Cartas al editor”
Revisión por pares
“Cartas al editor”
Revisión por pares
Externí odkaz:
http://hdl.handle.net/10757/624728
Autor:
Pritika Devi
Publikováno v:
Himalayan Journal of Health Sciences. :6-14
Guduchi is a plant also known as Tinospora cordifolia, having heart shaped leave, an herb of the family Menispermaceae native of hot areas of the Indian subcontinent. In our classical Ayurvedic texts, it is indicated to be beneficial in treating vari
Autor:
Jingchao Li, Yu Luo, Ziling Zeng, Dong Cui, Jiaguo Huang, Chenjie Xu, Liping Li, Kanyi Pu, Ruiping Zhang
Publikováno v:
Nature Communications. 13
Nanomedicine holds promise to enhance cancer immunotherapy; however, its potential to elicit highly specific anti-tumor immunity without compromising immune tolerance has yet to be fully unlocked. This study develops deep-tissue activatable cancer so
Publikováno v:
ACS applied bio materials. 2(5)
The in vivo delivery of therapeutic nanoparticles (NPs) represents a potentially powerful tool that can significantly alter the biological effects of pharmaceutically active compounds. Here, we report on sensitization of tumors to chemotherapy by amm
Coronavirus disease 2019 (COVID-19) is a remarkably contagious and pathogenic viral infection arising from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan, China. For the time being, COVID-19 is not tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______9436::24e8012a95cd0d4dfac9a0f728ac1127
https://hdl.handle.net/11454/79545
https://hdl.handle.net/11454/79545
Publikováno v:
Oncology research and treatment. 44(12)
Background: Multiple myeloma is a so far incurable malignant plasma cell disorder. During the past 2 decades, treatment paradigms substantially changed when novel drugs were introduced initially in treatment of relapsed disease and subsequently also
Autor:
C. Lahmamssi, Alexis Vallard, Majed Ben Mrad, Nicolas Magné, Nicolas Vial, Elisabeth Daguenet, Elodie Guillaume, Claire Bosacki, Omar Jmour, Amal Bousarsar
Publikováno v:
Bulletin du Cancer. 107:84-101
The management of patients undergoing immunosuppressive agents is really challenging. Based on precaution principle, it seems mandatory to stop immunosuppressive (or immunomodulating) agents during radiation. Yet, it is impossible in grafted patients
Publikováno v:
Journal of Oncology Pharmacy Practice. 26:1244-1247
Introduction Pomalidomide is an immunomodulating agent that is used to treat relapsed and/or refractory multiple myeloma. Although the incidence of hypersensitivity with pomalidomide is not well documented, the most common type of hypersensitivity in
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 18, Iss 4, Pp 59-66 (2019)
Relevance.Acute respiratory diseases (ARD) occupy a leading position in infectious pathology. Patients who often suffer from the acute respiratory diseases, in most cases have an ENT pathology against the background of immunodeficiency state. Large g